Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › flibanserin

flibanserin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of flibanserin

5 trials tracked of flibanserin: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 185 citations.

5Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 5
  1. Phase 3 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder Completed · 185 cited
  2. Phase 3 Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder Completed · 151 cited
  3. Phase 3 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA Completed
  4. Phase 3 Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder Completed
  5. Phase 3 Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.